NCT00285688

Brief Summary

Peptic ulcer disease is the most common gastrointestinal disease. Antibiotic resistant Helicobacter pylori is a major problem worldwide. The gold standard for Helicobacter pylori eradication is composed of Proton-pump inhibitor/Ranitidine bismuth citrate + Amoxycillin + Metronidazole /Clarithromycin. In Thailand, clarithromycin resistant strains increased and led to treatment failure. Data on file at Rajavithi Hospital showed that metronidazole resistant H. pylori was about 50% and Clarithromycin resistant strains accounted for 8%. This molecular genetic study will be performed in patients presenting with dyspepsia, who had an indication for gastroscopic examination, to explore the incidence of antibiotic resistant Helicobacter pylori in Rajavithi Hospital, Thailand.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 1, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 2, 2006

Completed
4 months until next milestone

Study Start

First participant enrolled

June 1, 2006

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2007

Completed
Last Updated

October 19, 2020

Status Verified

October 1, 2020

Enrollment Period

1.5 years

First QC Date

February 1, 2006

Last Update Submit

October 14, 2020

Conditions

Keywords

H. Pylori, Clarithromycin resistant, gene

Outcome Measures

Primary Outcomes (1)

  • Incidence of H. pylori Clarithromycin resistance gene

    one year

Secondary Outcomes (1)

  • Characteristic of H. pylori clarithromycin resistant gene mutation

    one year

Study Arms (2)

1

Gastroscope positive for H. pylori and resistant to clarithromycin

Procedure: gastroscopic examination

2

Gastroscope positive for H. pylori and not resistant to clarithromycin

Procedure: gastroscopic examination

Interventions

gastroscopic examination for tissue biopsy and real time PCR for gene study

12

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Dydpepsia patient with gastroscopic examination

You may qualify if:

  • male or female with dyspepsia
  • age \> 15 years
  • fulfil indication for gastroscopic examination
  • able to give informed consent

You may not qualify if:

  • contraindication for gastroscopic examination and biopsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rajavithi Hospital

Ratchathewi, Bangkok, 10400, Thailand

Location

Related Publications (1)

  • Hansomburana P, Anantapanpong S, Sirinthornpunya S, Chuengyong K, Rojborwonwittaya J. Prevalence of single nucleotide mutation in clarithromycin resistant gene of Helicobacter pylori: a 32-months prospective study by using hybridization real time polymerase chain reaction. J Med Assoc Thai. 2012 Mar;95 Suppl 3:S28-35.

Biospecimen

Retention: SAMPLES WITH DNA

Gastric Biopsy tissue and H. pylori DNA

MeSH Terms

Conditions

Dyspepsia

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Piyathida Harnsoomboon, MD

    Department of Medical Services Ministry of Public Health of Thailand

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

February 1, 2006

First Posted

February 2, 2006

Study Start

June 1, 2006

Primary Completion

December 1, 2007

Study Completion

December 1, 2007

Last Updated

October 19, 2020

Record last verified: 2020-10

Locations